Showing results (381-390 of 395) with videos related to
Sort By:
Pageof 40
The New England Journal of Medicine|June 3, 2014
Adjuvant exemestane with ovarian suppression in premenopausal breast cancerOlivia Pagani, Meredith M Regan, Barbara A Walley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization TrialMartine Piccart-Gebhart, Eileen Holmes, José Baselga, et al.The New England Journal of Medicine|June 5, 2018
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast CancerPrudence A Francis, Olivia Pagani, Gini F Fleming, et al.The New England Journal of Medicine|June 3, 2021
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast CancerAndrew N J Tutt, Judy E Garber, Bella Kaufman, et al.Breast (Edinburgh, Scotland)|July 31, 2025
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trialIsabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE TrialFedro A Peccatori, Samuel M Niman, Ann H Partridge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2024
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt PregnancyHatem A Azim, Samuel M Niman, Ann H Partridge, et al.ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancerP A Francis, O Pagani, G F Fleming, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2026
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) TrialOlivia Pagani, Samuel M Niman, Monica Ruggeri, et al.Pageof 40